US 2014/0194400 A1Published application

Nasal Pharmaceutical Formulation

AssigneeMEDA Pharma GmbH & Co. KG

InventorsAnnegret Hildebrand-Cyrener, Joachim Maus, Ullrich Munzel, Hans Tritschler, Mario Weingart

Life of this patent

Estimating the term…

Abstract

The present invention relates to a nasel formulation comprising as its active ingredient an intranasal corticosteroid, and also to a method for prophylaxis or treatment of seasonal or perennial allergic and non-allergic rhinitis and rhinoconjunctivitis.

Claims10

Dependent claims

A nasal pharmaceutical formulation comprising fluticasone or a pharmaceutically acceptable ester or salt thereof and optionally one or more auxiliaries.

Dependencies are inferred from the claim text.

Facts

Application: 14/122,561Filed 24 May 2012
Priority: DE 10 2011 103 347.927 May 2011
Published: 10 Jul 2014
Term ends: Not estimatedThe source records don’t support an estimate.

Classification8 codes

A61K 9/0043
Galenical forms characterised by the site of application: nose
A61K 9/08
Medicinal preparations characterised by special physical form: solutions
A61K 31/56
Medicinal preparations containing organic active ingredients: compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives…
A61P 11/02
Drugs for disorders of the respiratory system: nasal agents, e.g. decongestants

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results